Eloxx Pharmaceuticals Inc
General ticker "ELOX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $0.2
Eloxx Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -44.6%.
Estimated limits based on current volatility of 117.7%: low -0.00$, high 0.00$
Factors to consider:
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [1.75$, 6.32$]
- 2023-12-31 to 2024-12-30 estimated range: [1.21$, 3.88$]
Financial Metrics affecting the ELOX estimates:
- Negative: Non-GAAP EPS, $ of -16.52 <= 0.10
- Negative: Operating cash flow per share per price, % of -81.64 <= 2.35
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Interest expense per share, $ of 0.90 > 0.74
- Negative: Industry earnings per price (median), % of -20.11 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of -15.82 <= 3.85
- Negative: Industry inventory ratio change (median), % of 3.13 > 0.49
Short-term ELOX quotes
Long-term ELOX plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $33.45MM | $66.02MM | $34.42MM |
| Operating Income | $-33.45MM | $-66.02MM | $-34.42MM |
| Non-Operating Income | $-1.12MM | $-0.71MM | $-1.65MM |
| Interest Expense | $1.41MM | $1.26MM | $1.95MM |
| R&D Expense | $14.59MM | $45.57MM | $23.73MM |
| Income(Loss) | $-34.58MM | $-66.73MM | $-36.06MM |
| Profit(Loss) | $-34.58MM | $-66.73MM | $-36.06MM |
| Stockholders Equity | $10.23MM | $22.38MM | $-10.66MM |
| Assets | $26.48MM | $45.14MM | $21.12MM |
| Operating Cash Flow | $-28.17MM | $-35.00MM | $-31.84MM |
| Capital expenditure | $0.00MM | $0.09MM | $0.07MM |
| Investing Cash Flow | $33.79MM | $2.06MM | $-0.07MM |
| Financing Cash Flow | $-3.44MM | $50.79MM | $8.81MM |
| Earnings Per Share* | $-34.47 | $-38.15 | $-16.65 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.